language_icon
EN
HI

Shelter Pharma Share price

SHELTER

30.4

0.20 (-0.65%)
Last updated on 30 Apr, 2026 | 15:24 IST
Today's High

30.40

Today's Low

29.85

52 Week Low

26.50

52 Week High

50.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Shelter Pharma Chart

Shelter Pharma Share Key Metrics

Volume
24000.00
Market Cap
49.98 CR
LTQ@LTP
3000@30.40
ATP
30.23
Var Margin
53.5 %
Circuit Range
24.48-36.72
Delivery %
87.5 %
Value
7.26 L
ASM/GSM
No
Market Lot
3000

Summary

Shelter Pharma share price stands at ₹30.4 at 30 Apr, 2026 | 15:24. The stock Shelter Pharma intraday movement has stayed between ₹29.85 and ₹30.40, while on a 52-week basis it has fluctuated from ₹26.50 to ₹50.00.
In terms of trading activity, Shelter Pharma has recorded a volume of 24000 shares. The Shelter Pharma has a market cap of ₹16332792. The stock’s Average Traded Price (ATP) stands at ₹3023, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3000, 3040.
The Shelter Pharma operates within a circuit range of ₹24.48-36.72 – ₹24.48-36.72, with a Value of ₹7.26 L. The Delivery Percentage for the day is 87.5%. Additionally, Shelter Pharma currently falls under the No framework, and trades with a market lot size of 3000.

Shelter Pharma Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

Shelter Pharma Resistance and Support

Pivot 30.27

Resistance

First Resistance

31.24

Second Resistance

31.89

Third Resistance

32.86

Support

First Support

29.62

Second Support

28.65

Third Support

28

Shelter Pharma Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

44.99%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

55.01%

Others

0%

Total Promoters
MAR '26
44.99%

Shelter Pharma Corporate Actions

DateAgenda
2025-11-10Half Yearly Results
2025-09-02A.G.M. & Final Dividend
2025-06-26Preferential Issue of shares & Others
2025-06-18To consider Fund Raising
2025-05-29Audited Results
2025-01-08Others

Shelter Pharma News

Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Shelter Pharma secured an order worth $144,000 from Taha Drugs & Chemicals Co. Ltd for Joemega Capsule and All Vitamins tablet. The order is from an international entity in Sudan and will be executed within two months.
Apr 29 2026 12:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Update On Export Operation

Shelter Pharma commenced dispatch of products for export to Sudan, including its 'Allvitamin' multivitamin supplement. This initiative expands its regular export supply to African markets, contributing to revenue diversification and strengthening global presence.
Apr 16 2026 12:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion Plans

Shelter Pharma Limited appointed key senior management personnel, including a Zonal Sales Manager, Regional Sales Manager, sales officers, and an Export Executive. This strategic move aims to strengthen the company's sales hierarchy, improve operational efficiency, and expand market presence both domestically and internationally.
Apr 15 2026 13:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 For Hiring Of Senior Management Personnel In Line With Business Expansion Plans

Shelter Pharma has initiated a structured hiring process for senior management roles. This move aligns with the company's strategic expansion plans across domestic markets and aims to strengthen the management team, enhance operational efficiency, and support long-term business growth.
Apr 07 2026 12:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements ) Regulation, 2015 Reciept Of Negotiation Meeting Intimation From Verka Dairies ( Punjab State Co Operative Milk Producers Federation Limited )

Shelter Pharma Ltd qualified the technical evaluation for a tender to supply veterinary medicines to Verka Dairies. The company has been invited for a negotiation meeting for this potential business deal, reflecting its growing presence in the veterinary healthcare segment.
Apr 06 2026 11:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousures Requirements) Regulations, 2015 Positive Customer Feedback On Companies Products

Shelter Pharma Limited received positive customer feedback on its product range. This feedback reflects strong customer satisfaction in terms of quality and effectiveness, which the company expects to favorably impact brand value and business growth without immediate financial impact.
Apr 02 2026 16:04:00

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI ( LODR ) New Product Now Available In The Market

Shelter Pharma Limited successfully launched its new product 'FitKick Pro', making it commercially available from March 30, 2026. The product, designed for improved endurance and focus, is now available on platforms like Amazon.
Apr 01 2026 11:04:00
Read More

About Shelter Pharma

NSE : 0  
BSE : 543963  
ISIN : INE013V01011  

The Company was originally converted from a Partnership Firm “M/s Shelter Pharma” to a Public Limited Company on October 12 2007 as “Shelter Pharma Limited” under the provisions of the Companies Act 1956 with the Registrar of Companies Gujarat Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.The Company is promoted by Mr. Mustaqim Nisarahmed Sabugar and Mr. Shakil Nisarahmed Sabugar. The Company primarily focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter started with a few products about decades back. However over a period of time it has added products to its portfolio through its in-house R & D efforts backed by sound knowledge of Ayurveda. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. It enjoys a good product acceptance and market share in the state of Gujarat. In the Human pharma segment Shelter has product portfolio of OTC products as well Ethical pharma products. Similarly Shelter has OTC and Ethical presence in Veterinary segment. Shelter has a respectable track record of efficacy of its products. All the products are priced very competitively considering Shelter’s target market.Shelter Pharma Limited originally named as Shelter Pharmacy it was converted to Shelter Pharma Limited on 12th Day of October 2007 under Part IX of The Companies Act 1956. The company is being promoted by Mr. Mustaqim Nisarahmed Sabugar and Mr. Shakil Nisarahmed Sabugar. Promoters have nurtured and strengthened the business over the years. The business was slowly expanded from local presence in Himmatnagar to well spread presence in the state of Gujarat. Shelter remained a family enterprise before incorporation of the Company with a consolidated position in Gujarat. Introduction of new generation of promoters set up of new companies around 2007 brought new ideas and aspirations to the business. Shelter has embarked on a major restructuring drive in line with redefined goals and objectives for last 4 years. The company has reworked its organizational structure product portfolio distribution network pricing packaging and internal processes. It has also invested substantially in strengthening infrastructure with fresh fund infusion to improve its manufacturing capacity in Himmatnagar. Shelter sources required raw material fromnearby villages. the raw material is sourced directly from farmers. Company has long established relationships with farmers giving it an assured supply of herbs and plants. Shelter focuses on rural/semi urban market as its clientele to offer high quality price competitive remedies to villages.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of “Shelter Pharma Limited”2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023

Read More

Shelter Pharma Management

NamePosition
Mustaqim Nisarahmed SabugarManaging Director
Shakil Nisarahmed SabugarWhole Time Director
View More

Shelter Pharma FAQs

The Buying Price of Shelter Pharma share is 30.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Shelter Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shelter Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Shelter Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Shelter Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Shelter Pharma’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Shelter Pharma is 49.98 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Shelter Pharma share price is 50.00 & 26.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Shelter Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost